Evaluating dexamethasone-sparing regimens in frail patients with newly diagnosed myeloma
7 months ago
[{"url":"https://i.ytimg.com/vi/S-wDe7EOR8w/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLC5v4tKeyIbqWKC_NvkXmaj-0yHFg","width":360,"height":202},{"url":"https://i.ytimg.com/vi/S-wDe7EOR8w/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLAaClir6rw5vNTgaVRARGOT1VyeXg","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/S-wDe7EOR8w/mqdefault_6s.webp?du=3000&sqp=CPjzsKkG&rs=AOn4CLAT_rcfd5FicDdVBQFaWpukGlfNKw","width":320,"height":180}
[{"text":"Meral Beksac, MD, Ankara University, Ankara, Turkey, shares some insights into the IFM2017-03 trial (NCT03993912), which is\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Evaluating dexamethasone-sparing regimens in frail patients with newly diagnosed myeloma by VJHemOnc \u2013 Video Journal of Hematological Oncology 35 views 7 months ago 1 minute, 33 seconds","duration":"1 minute, 33 seconds"}